Wednesday January 20, 2016 0 comments
CENTENNIAL -- AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgery and wound care, announced it has been awarded U.S. Patent No. 9,186,253 for its new cartilage repair allograft, ProChondrix Cartilage Restoration Matrix.
ProChondrix is a cellular 3D fresh cartilage matrix that helps deliver the necessary components for cartilage restoration, AlloSource said.
“With thousands of cartilage repair surgeries performed in the U.S. each year, this is another opportunity for donor tissue to improve lives,” said Dr. Peter Stevens, AlloSource VP of development and growth. “The initial feedback from surgeons on ProChondrix has been positive, and we look forward to continued collaboration in helping patients heal.”
AlloSource said it has grown into one of the nation’s largest tissue networks by focusing on quality, safety, service and a commitment to its mission.
The company said its safety and tissue processing standards meet and exceed guidelines set by the U.S. FDA and the American Association of Tissue Banks.